MEF2C and pancreatic adenocarcinoma: MEF2C has recently been proposed as a new oncogene, promoting metastasis in pancreatic adenocarcinoma by inducing MMP10 transcription (Zhang et al., 2014) and mediating VEGF induction of vasculogenic mimicry, migration, and invasion in hepatocellular carcinoma (Bai et al., 2015).